Author

R. Brugés

h-index 10 View on Semantic Scholar

We have 3 of 63 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Prognostic associations of PD-L1 expression and BAP1 loss in pleural mesothelioma: a retrospective single-center cohort from Colombia

Background Evidence on the prognostic associations of programmed death-ligand 1 (PD-L1) and BRCA1-associated protein 1 (BAP1) in pleural mesothelioma (PM) remains inconsistent, and joint data from Latin American cohorts are limited. We evaluated these biomarkers in a Colombian cohort. Methods This retrospective single-...

R. Brugés, C. Carvajal, A. Luna Meza et al. · Frontiers in Oncology · 0 citations

Open access Jan 2026

Real‐World Outcomes of Immune Checkpoint Inhibitors in Melanoma, Including Acral and Mucosal Subtypes: A Retrospective Cohort Study From a Latin American Center

Background Real‐world evidence on immune checkpoint inhibitors (ICIs) in Latin American patients with melanoma remains limited, particularly for acral and mucosal subtypes. We evaluated survival, radiologic response, immune‐related adverse events (irAEs), and exploratory factors associated with outcomes in a Colombian...

Vaneza Ávila-Rodríguez, J. M. Vasquez, L. Molina-Pimienta et al. · Journal of Skin Cancer · 0 citations

Open access Sep 2026

Sociodemographic and Clinicopathologic Characteristics of Patients With Invasive Breast Cancer in Latin America: The LATINA Breast Cohort (LACOG 0615/MO39485).

A substantial proportion of BC cases in LATAM are diagnosed symptomatically and at advanced stages, and late-stage presentation is associated with sociodemographic characteristics and type of health care coverage.

G. Werutsky, Cynthia Villarreal-Garza, A. Ferrigno Guajardo et al. · JCO Global Oncology · 0 citations